10.4103/jfmpc.jfmpc_1864_21 Miller Fisher syndrome associated with COVID 19

被引：0

作者：

Yaqoob, Arjimand ^{[1
]}

Dar, Waseem ^{[1
]}

Khuja, Zubair ^{[1
]}

Bukhari, Immia ^{[1
]}

Raina, Adnan ^{[1
]}

Ganie, Hilal ^{[1
]}

Chandra, Amit ^{[1
]}

Wani, Maqbool ^{[1
]}

Wani, Faizan ^{[2
]}

机构：

[1] SKIMS, Dept Neurol, Srinagar, Jammu & Kashmir, India

[2] SKIMS, Dept Gen Med, Srinagar, Jammu & Kashmir, India

来源：

JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE | 2022年 / 11卷 / 07期

关键词：

COVID-19; GBS; MFS; SARS-CoV-2;

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Miller Fisher syndrome (MFS), is an acute peripheral neuropathy, a variant of Guillain-Barre syndrome, that develops following exposure to different viral, bacterial, and fungal pathogens. Patients usually present with a triad of ophthalmoplegia, ataxia, and areflexia. During Covid pandemic MFS has been described associated with novel coronavirus disease 2019 (COVID-19). Here we describe the clinical course, Cerebrospinal fluid (CSF) findings, nerve conduction studies, treatment and outcome of the patient having MFS concurrent with COVID 19.

引用

页码：4023 / 4025

页数：3

共 50 条

[41] A CASE OF MILLER FISHER SYNDROME ASSOCIATED WITH PRECEDING HERPES ZOSTER OPHTHALMICUS
Rizzo, Angelo Cascio
Ulivi, Martina
Brunelli, Nicoletta
Pepe, Alessio
Assenza, Giovanni
Florio, Lucia
Di Lazzaro, Vincenzo
MUSCLE & NERVE, 2017, 55 (04) : E15 - E16
[42] COVID-19 Induced Miller Fisher Syndrome Presenting With Autonomic Dysfunction: A Unique Case Report and Review of Literature
Biswas, Subhrajyoti
Ghosh, Ritwik
Mandal, Arpan
Pandit, Alak
Roy, Dipayan
Sengupta, Samya
De, Kaustav
Swaika, Bikash Chandra
Benito-Leon, Julian
NEUROHOSPITALIST, 2022, 12 (01): : 111 - 116
[43] Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement
Senel, M.
Abu-Rumeileh, S.
Michel, D.
Garibashvili, T.
Althaus, K.
Kassubek, J.
Otto, M.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (11) : 2378 - 2380
[44] Miller Fisher syndrome associated with bulbar paralysis and elevation of antibodies against gangliosides
Bandou, N
Ise, M
Akita, H
Kozan, H
Sekiguchi, T
Ohara, K
Okamoto, T
Asano, A
Yoshino, H
PEDIATRICS INTERNATIONAL, 1999, 41 (06) : 685 - 688
[45] Miller-Fisher syndrome associated with unilateral cerebral white matter lesions
Xu, Yongfeng
Liu, Lan
NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2015, 49 (05) : 344 - 347
[46] GQ1b-Seronegative Miller Fisher Syndrome Associated With Pembrolizumab
Green, Kemar E.
Levine, Anna M.
Ward, Jayne H.
Kaufman, David I.
JOURNAL OF NEURO-OPHTHALMOLOGY, 2019, 39 (03) : 394 - 396
[47] Clinical characteristics and prognosis of temporary miller fisher syndrome following COVID-19 vaccination: a systematic review of case studies
Alijanzadeh, Dorsa
Soltani, Afsaneh
Afra, Fatemeh
Salmanpour, Fardis
Loghman, Amir Hossein
Samieefar, Noosha
Rezaei, Nima
BMC NEUROLOGY, 2023, 23 (01)
[48] Clinical characteristics and prognosis of temporary miller fisher syndrome following COVID-19 vaccination: a systematic review of case studies
Dorsa Alijanzadeh
Afsaneh Soltani
Fatemeh Afra
Fardis Salmanpour
Amir Hossein Loghman
Noosha Samieefar
Nima Rezaei
BMC Neurology, 23
[49] Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: Case report and scope review
Liang, Hao
Cao, Yuanbo
Zhong, Wei
Ma, Zhenwang
Liu, Jia
Chen, Hong
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
[50] A case of Miller Fisher syndrome with delayed onset peripheral facial nerve palsy after COVID-19 vaccination: a case report
Kentaro Nanatsue
Makoto Takahashi
Sakiko Itaya
Keisuke Abe
Akira Inaba
BMC Neurology, 22

← 1 2 3 4 5 →